Babler Martin
CIK 0001435618
President, CEO and ChairmanDirector
Filings
14
Latest Jan 28, 2026
Issuers covered
4
Showing
14 of 14
Page 1
Track record
1 of 1 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 1 | 0% | -47.1% | -47.1% | -47.1% | -47.1% |
| 90 days | 1 | 0% | -58.6% | -58.6% | -58.6% | -58.6% |
| 180 days | 1 | 0% | -45.4% | -45.4% | -45.4% | -45.4% |
| 365 days | 1 | 100% | +214.0% | +214.0% | +214.0% | +214.0% |
Issuers
Companies where Babler Martin has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ALMS | Alumis Inc. | 5 | Jan 28, 2026 |
| PRLD | Prelude Therapeutics Inc | 4 | Jun 13, 2025 |
| ETNB | 89bio, Inc. | 3 | Oct 30, 2025 |
| NGNE | Neurogene Inc. | 2 | Jun 9, 2023 |
All filings
14 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|